Incontinence patch goes over-the-counter

July 1998
FDA Consumer;Jul/Aug98, Vol. 32 Issue 4, p5
Reports on the approval of the over-the-counter sale of `UroMed Patch' by the United States Food and Drug Administration. Use of this patch to help women reduce leakage from stress urinary incontinence; Amount of Americans affected by urinary incontinence; Information on the patch manufactured by UroMed Corporation; Identity of one of the main side effects from the use of this patch.


Related Articles

  • Botox OK for incontinence. Gustafson, Mary // McKnight's Long-Term Care News;Oct2011, Vol. 32 Issue 10, p3 

    The article reports on the approval of Botox (botulinum toxin type A) by the U.S. Food and Drug Administration (FDA) for treating incontinence in patients with neurologic conditions including spinal cord injury and overactive bladder.

  • Botulinum toxin: Cost-effective for urge incontinence. Guttman, Cheryl // Urology Times;12/1/2008, Vol. 36 Issue 15, p5 

    The article reports on the data presented by researchers from Duke University which reveals the cost-effectiveness of Botulinum toxin (Botox) for urge incontinence treatment. The data, which utilized a Markov decision analysis model, shows that Botox is a cost effective strategy for the...

  • FDA Actions.  // Neurology Alert;Jan2009 Pharmacology Watch, p2 

    The article reports on the approval of fesoterodine fumarate for the treatment of overactive bladder by the U.S. Food and Drug Administration (FDA). Manufactured by SchwartzPharma, the drug relaxes smooth muscle of the bladder reducing urinary frequency, urge to urinate, and sudden urinary...

  • New drug treats overactive bladder without drying mouth. LoBuono, Charlotte // Drug Topics;1/10/2005, Vol. 149 Issue 1, p18 

    This article reports on the approval of solifenacin for the treatment of overactive bladder with symptoms of urgency, urinary frequency, and urge urinary incontinence by the U.S. Food and Drug Administration. According to physician Peter Sand, a professor of obstetrics and gynecology and...

  • Product Briefs.  // Medical Device Daily;3/5/2012, Vol. 16 Issue 43, p10 

    This section offers news briefs from the U.S. medical device industry. Premarket approval from the U.S. Food and Drug Administration (FDA) has been expanded for the Absolute Pro self-expanding stent system from Abbott. The first bench tests for the Bluetooth-based telemetry controlled system...

  • CLINIC ROUNDUP.  // BioWorld Today;3/10/2009, Vol. 20 Issue 45, p11 

    This section offers news briefs concerning clinical trials. Phase I trial of AOBO-001, a capsule for urinary incontinence based on traditional Chinese herbal medicine, will be conducted by American Oriental Bioengineering Inc. Clinical benefits were found by AndroScience Corp. from its ASC-J9...

  • BOTOX for bladder control. LOTEMPIO, SUSAN M. // New Mobility;Oct2013, Vol. 24 Issue 241, p14 

    The article offers the author's insight on her experience of Botox injections to regain control of her bladder. She relates her experience of work-related stress due to urinary incontinence and its impact on the quality of her life and those who have the disorder. She discusses how the Botox...

  • Beech Tree Labs' Urinary Incontinence Trial Begins.  // Biomedical Market Newsletter;5/14/2011, p267 

    The article focuses on the initiation of Beech Tree Labs Inc.'s Phase 1/2a clinical trial of its therapeutic agent UISH001 for urinary incontinence (UI). This placebo-controlled study, will be conducted on 60 patients and has been approved by the U.S. Food and Drug Administration (FDA). Beech...

  • Gelnique (Oxybutynin Chloride) 10% Gel for Overactive Bladder. Lajiness, Michelle J. // Urologic Nursing;Jul/Aug2010, Vol. 30 Issue 4, p253 

    The article presents information about Gelnique® a branded oxybutinin transdermal gel from Watson Pharmaceuticals. Approved by the U.S. Food and Drug Administration (FDA), the medication is used to treat symptoms of overactive bladder, which include urinary incontinence and urgency. Some...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics